Lataa...
A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses
TLR4 agonists can be used as adjuvants to trigger innate immune responses of antigen-presenting cells (APCs) such as dendritic cells (DCs) to enhance vaccine-specific immunity. Adjuvant effects of TLR4 agonists are mediated by downstream signaling controlled by both MyD88 and TRIF adapter proteins....
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3360926/ https://ncbi.nlm.nih.gov/pubmed/22314134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.01.074 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|